Диссертация (1174201), страница 49
Текст из файла (страница 49)
- № 38. –Р.1096-1102.326.Kannel, W. Risk stratification in hypertension: new insights from theFramingham Study / W. Kannel // Am. J. Hyper. – 2000. – V.13, № 2. – P. S3-S10.327.Kannel, W. Systolic versus diastolic blood pressure and risk of coronaryheart disease The Framingham study / W. Kannel, T. Gordon, M. Schwartz // Am. J.Cardiol. – 1971. – V. 27. – P. 335-346.328.Kannel, W.B. Left ventricular hypertrophy as a risk factor / W.B.
Kannel// J. Hypertens. – 1991. – V. 9, № 2. – P. S3-S9.329.Kaplinsky, E. Significance of left ventricular hypertrophy in cardiovas-cular morbidity and mortality / E. Kaplinsky // Cardiovasc. drugs and therapy. –1994. – V. 8. – Р. 549-556.330.Kapoor, W.N. Syncope and Hypotension / In: Heart Disease / Ed. E.Braunwald, W.B. Saunders. – 1997. – P. 863-876.331.Kohlmann, T. Germen verstonof Nottingham Health Profile (NHP):transeation and puychometric validation /T. Kohlmann, M. Buitlinger, J. Kirchbergor-Blumstein // Saz.
Praventivmed. – 1997. – Vol. 3. – P. 175-185.321332.Korner, P. I. Cardiac baroreflex in hypertension / P. I. Korner // Clin. andexperim. hypertension. – 1995. – V. 17, № 1. – Р. 425-439.333.Kuusisto, J. Non-insulin-dependent diabetes and its metabolic control areimportant predictors of stroke in elderly subjects / J. Kuusisto, L. Mykkanen, K.Pyorala // Stroke. – 1994. – V. 25.
– P. - 1157-1164.334.Larson, M.G. Assessment of cardiovascular risk factors in the elderly:the Framingham heart study / M.G. Larson // Stat. Med. – 1995. – V. 14. – P. 17451756.335.Launer, L.J. The association between midlife blood pressure and late-lifecognitive function: the Honolulu-Asia Aging Study / L.J. Launer, K. Masaki, H.
Petrovitch // JAMA. – 1995. – V. 274. – P. 1846-1851.336.Launer, L.J. Nonresponse pattern and bias in a community-based cross-sectional study of cognitive functioning among the elderly / L.J. Launer, A.W. Wind,D.J.H. Deeg // Am J Epidemiol. – 1994. - V.
139. – P. 803- 812.337.Left ventricular geometric patterns and QT dispersion in untreated essen-tial hypertension / Z. Bugra [et al.] // Am. J. Hypertens. – 1998. – V. 11, №10. – P.1164-1170.338.Lever, A.F. MRC trial of treatment in elderly hypertensives. / A.F. Lev-er, P.J. Brennan // Clin Exp Hypertens. – 1993. – V.
15. – P. 941–942.339.Lithell, H. The Primary Preventive Study in Uppsala: fatal and non-fatalmyocardial infarction during a 10-year follow-up of a middle-aged male populationwith treatment of high-risk individuals / H. Lithell, H.
Aberg, I. Selinus // Acta MedScand. – 1984. – V. – 215. – P. 403-409.340.Longitudinally measured blood pressure, antihypertensive medicationuse, and cognitive performance: the Framingham Study / Farmer [et al.] // Journal ofClinical Epidemiology. – 1990. – V. 43. – P. 475-480.341.Maheshwari, V.D.
QT dispersion as a marker of left ventricular mass inessential hypertensin / V.D. Maheshwar, M.P. Giris // Indian. Heart. J. – 1998. – V.50, № 4. – P. 414-417.322342.Maher, R.L. Clinical consequences of polypharmacy in elderly / R.L.Maher, J. Hanlon, E.R. Hajjar // Expert Opin Drug Saf. – 2014. – V. 13. - P.
57–65.343.Maslow, A.H. Motivation and Personality. / A.H. Maslow // New York,Harper & Brothers, 1954. – P. 241–246.344.Measure of blood pressure and miocardial infarction in treated hyperten-sive patients / J. Fang [et al.] // J. Hypert. – 1995. – V. 13. – P. 413-419.345.Middlekauff, H.R. Prognosis after syncope: impact of left ventricularfunction / H.R. Middlekauff, W.G. Stevenson, L.A. Saxon // Am.
Heart. J. – 1993. –V. 125. – P. 121-127.346.Moss, A.J. Measurement of the QT interval and the risk associated withQTc interval prolongation: a review / A.J. Moss // Am. J. Cardiol. – 1993. – V. 72. –P. 23B-25B.347.Morbidity and mortality in the Swedish trial in old patients with hyper-tension (STOP-Hypertension). / B.
Dahlof [et al.] / Lancet. – 1991. - № 338. – Р.1281-1285.348.MRC Working Party Medical Research Council Trial of treatment ofhypertension in order adults: principal results // British Medical Journal. - 1992. - V.304. - P. 405-412349.Murray, M.D. Preservation of cognitive function with antihypertensivemedication: a longitudinal analysis of community-based sample of African Americans / M.D. Murray, K.A. Lane, S. Gao // Arch Intern Med. – 2002. - V. 162. – P.2090–2096.350.Mustard, C.A. Case (control study) of exposure to medication and therisk of injurious falls requiring hospitalization among nursing home residents / C.A.Mustard, T.
Mayer // Am. J. Epidemiol. – 1997. – V. 145. – P. 738-745.351.Nagai, Y. Blood-flow velocities and their relationships in carotid andmiddle cerebral arteries / Y. Nagai, M.K. Kemper, C.J. Earley // Ultrasound. Med.Biol. – 1998. – V. 24, № 8. – P. 1131-1136.352.Nielsen, W.B. Isolated systolic hypertension as a major risk factor forstroke and myocardial infarction and an unexploited source of cardiovascular preven-323tion: a prospective population-based study / W.B. Nielsen, J.
Vestbo, G.B. Jensen //Hypertension. – 1995. – V 9. – P.175 – 180.353.Nocturnal fall of blood pressure and silent cerebrovascular damage in el-derly hypertensive patients / K. Kario [et al.] // Hypertension. – 1996. - № 27. – P.130-135.354.Normal ageing, impaired cognitive function, and senile dementia of theAlzheimer's type: a continuum? / C. Brayne, P. Galloway // Lancet. – 1988. - № 1. –Р.
1265-1267.355.Nyenhuis, D.L. Vascular dementia: A contemporary review of epidemi-ology, diagnosis, prevention and treatment. / D.L. Nyenhuis, P.B. Gorelick // J AmGeriatr Soc. – 1998. – V. – 46. – P. 1437–1448.356.Occurrence and relevance of postprandial hypotension in patient with es-sential hypertension / P. Mitro [et al.] // Wien. Klin. Wochenschr. – 1999. – V. 111,№ 8.
– P. 320-325.357.Optimal blood pressure control in treated hypertensive patients / C.J.Bulpitt [et al.] // Circulation. – 1994. – V. 90, № 1. – Р. 225-233.358.Orthostasis as a test for cerebral autoregulation in normal persons andpatients with carotid artery disease / M. Stoll [et al.] // J. Neuroimaging. – 1999. – V.9, № 2. – P. 113-117.359.Orthostatic hypotension in the aged and its association with antihyper-tesive treatment / T. Saez [et al.] // Med.
Clin. Barc. – 2000. – V. 114, № 14. – P.525-529.360.Orthostatic hypotension predicts mortality in elderly men the Honoluluheart program / H.M. Kamal [et al.] // Circulation. – 1999. – V. 98, № 21. – P. 22902295.361.Orthostatic hypotension predicts all-cause mortality and coronary eventsin middle-aged individuals (The Malmo Preventive Project) / A. Fedorowski [et al.] //Eur Heart J. – 2010. – V. 31. – P. 85–91.324362.Patrick, A. Davey QT interval lengthening in cardiac disease relatesmore to left ventricular systolic dysfunction than to autonomic function / A. Patrick //Eur. J. Heart Failure. – 2000. – V. 2, № 3. – P.
265-271.363.Patterns of orthostatic blood pressure change and their clinical correlatesin a frail, elderly population / W.L. Ooi [et al.] // JAMA. – 1997. – V. 277. – P. 12991304.364.Pearson, A.P. Left ventricular hypertrophy, diagnosis, prognosis, man-agement / A.P. Pearson, F. Pasiercki // Am. Heart. J. – 1991.
– V. 121. – P. 148-157.365.Petrovich, H. Isolated systolic hypertension and risk of stroke in Japa-nese-American men / H. Petrovich, J. Curb, E. Bloom-Marcus // Stroke. – 1995. – V.26. – P. 25-29.366.Prevalence and persistency of orthostatic blood pressure fall in older pa-tients with isolated systolic hypertension / H. Vanhanen [et al.] // J. Hum. Hypertens.– 1996. – V. 10, № 9.
– P. 607-612.367.Prevalence, predisposing factors and prognostic importance of posturalhypotension / I. Raiha [et al.] // Arch. Intern. Med. – 1995. – V. 155, № 9. – P. 930935.368.Prince, M. J. Do antiarthritic drugs decrease the risk for cognitive de-cline? An analysis based on data from the MRC treatment trial of hypertension inolder adults // M. J. Prince, S. Rabe-Hesketh, P. Brennan // Neurology. – 1998. – V.50.
– P. 374-379.369.Polypharmacy in the aging patient: management of hypertension in octo-genarians / A. Benetos [et al.] // JAMA. – 2015. – V. 314. – P. 170–180.370.Prognosis of diastolic and systolic orthostatic hypotension in older per-sons / H. скinen [et al.] // Arch. Intern. Med. – 1999. – V. 159, № 3. – P. 273-280.371.Prolonged QT interval predicts cardiac and all-cause mortality in the el-derly. The Rotterdam Study / M.C. de Bruyne [et al].
// Eur. Heart J. – 1999. – V. 20.– P. 278-284.372.Prolonged QT interval: a tricky diagnosis? / M.C. de Bruyne [et al.] //Am. J. Cardiol. – 1997. – V. 80. – P.1300-1304.325373.QT-interval prolongation predicts cardiovascular mortality in an appar-ently healthy population / E.G. Schouten [et al.] // Circulation. – 1991. – V. 84. – P.1516-1523.374.Quality of life and hypertension: Where do we stand? New methods,new possibilities: definition a measurement of quality of life from a medical perspective / Ed.
I. Wiklund [et al.] – Stockholm. – 1990. – Suppl. 1. - 96 p.375.Quality of life in older patients with systolic and diastolic heart failure /T. Jaarama [et al.] // Eur. J. Heart Failure. – 1999. – Vol. 2. – P. 151-160.376.Quetelet, L.A.J. Antropometrie ou mesure des differentes facultes del’homme / L.A.J. Quetelet // Brussel, 1870.377.Reexamining the effect of antihypertensive medications on falls in oldage / L.A.
Lipsitz [et al.] // Hypertension. – 2015. – V. 66. – P. 183–189.378.Relationship between hyperglycemia and cognitive function in olderNIDDM patients / G.M. Reaven [et al.] // Diabetes Care. – 1990. – V. – 13. – P. 1621.379.Relation of left ventricular hypertrophy and geometry to asymptomaticcerebrovascular damage in essential hypertension / K. Kohara [et al.] // Am.
J. Cardiol. – 1999. – V. 83, № 3. – P. 367-370.380.Reproducibility of the Westminster tilt protocol / M.E. Petersen, R.Chamberlain-Webber, A.P. Fitzpatrick // J. Am. Coll. Cardiol. – 1992. – V. 19. – P.340-342.381.Rieckert, H. Orthostatic hypotension: how to avoid it during antihyper-tensive therapy / H. Rieckert // Am. J. Hypertens. – 1996. – V. 9. – P. 115S-159S.382.Risk factor modification in stroke prevention: the experience of a strokeclinic / L.N. Joseph [et al.] // Stroke. – 1999. – V.